Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism

BACKGROUND: Vitamin K antagonists (VKA) such as warfarin or phenprocoumon have been the mainstay of therapy for long‐term oral anticoagulant therapy (OAT) in patients with atrial fibrillation or with pulmonary embolism. Due to interferences with matrix Gla‐protein, an important vitamin K‐dependent l...

Descripción completa

Detalles Bibliográficos
Autores principales: Stöhr, Robert, Dirrichs, Timm, Kneizeh, Kinan, Reinartz, Sebastian, Frank, Dario, Brachmann, Johannes, Schroeder, Joerg, Schurgers, Leon, Göttsch, Claudia, Keszei, Andras, Floege, Jürgen, Marx, Nikolaus, Brandenburg, Vincent, Schuh, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Study Design
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019879/
https://www.ncbi.nlm.nih.gov/pubmed/35332571
http://dx.doi.org/10.1002/clc.23819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019879/
https://www.ncbi.nlm.nih.gov/pubmed/35332571
http://dx.doi.org/10.1002/clc.23819

Ejemplares similares